xx xx xx xx
xx PHARMACOLOGY 12TH EDITION BY SUSAN FORD
xx xx xx xx xx
CHAPTER 1-54 | COMPLETE GUIDE
xx xx xx xx xx
, Chapter 01: General Principles of Pharmacology
xx xx xx xx xx
Ford: Introductory Clinical Pharmacology 12th Edition
xx xx xx xx xx
1. Afterxxteachingxxa xxgroup xxof xxlearnersxxaboutxxthexxbasics xxofxxpharmacology, xxthe
xxlearners xxwill xxbe xxable xxto xxchoose xxwhich xxaspect xxas xxthe xxmost xxcritical xxto
xxremember?
A) Drug xxname
B) Drug xxclass
C) Drug xxaction
D) Drug xxsource
ACCURATE xxCHOICE:-C
Reasoning xx:->> xxPharmacology xxis xxthe xxstudy xxof xxdrugs xxand xxits xxaction xxon
xxliving xxorganisms. xxThus, xxan xxessential xxaspect xxof xxpharmacology xxis xxdrug
xxaction. xxAn xxunderstanding xxof xxthe xxdrug xxname, xxdrug xxclass, xxand xxdrug xxsource
xxis xximportant, xxbut xxthe xxmost x x critical xxaspect xxrelated xxto xxpharmacology xxis
xxhow xxthe xxdrug xxacts xxin xxthe xxbody.
Question xx x x Format:
xxMultiple xxChoice xxChapter:
xx1
Learning xxObj: xx1 xxCognitive
xxLevel: xxApply
Hospital xxclient xxNeeds: xxPhysiological xxIntegrity: xxPharmacological
xxTherapies xxIntegrated xxProcess: xxTeaching/Learning
Reference: xxp. xx3, xxIntroduction
2. A xxnursing xxattendant xxsuspects xxthe xxhospital xxclient xxhad xxan xxadverse
xxreaction xxto xxa xxprescribed xxmedication xxdue xxto xxan xxinteraction xxwith xxan
xxunreported xxover-the-counter xxsupplement. xxWhich xxaction xxby xxthe xxnursing
xxattendant xxwill xxbest xxassist xxin xxpreventing xxfuture xxsimilar xxincidents?
A) File xxa xxreport xxwith xxMedWatch
B) File xxa xxreport xxwith xxthe xxState xxBoard xxof xxNursing
C) Instruct xxthe xxhospital xxclient xxto xxavoid xxcombining xxmedications xxin xxthe xxfuture
D) Document xxthe xxincident xxand xxreport xxit xxto xxthe xxprimary xxhealth xxcare xxprovider
ACCURATE xxCHOICE:-A
Reasoning xx:->> xxProfessional xxnurses xxplay xxan xximportant xxrole xxin xxmonitoring
xxfor xxadverse xxreactions. xxTherefore, xxit xxis xximportant xxto xxsubmit xxreports, xxeven xxif
xxthere xxis xxuncertainty xxabout xxthe xxcause–effect xxrelationship. xxThe xxFDA xxprotects
xxthe xxidentity xxof xxthose xxwho xxvoluntarily xxreport xxadverse xxreactions.
Question xx x x Format:
,xxMultiple xxChoice xxChapter:
xx1
Learning xxObj: xx9 xxCognitive
xxLevel: xxApply
, Hospital xxclient xxNeeds: xxSafe xxand xxEffective xxCare xxEnvironment: xxSafety xxand xxInfection
xxControl
Integrated xxProcess: xxClinical xxProblem-solving xxProcess xx(Nursing
xxProcess) xxReference: xxp. xx7, xxBox xx1.1 xxMedWatch xxand xxReporting
xxAdverse xxEvents
3. A xxnursing xxattendant xxis xxassessing xxa xxhospital xxclient xxand xxnotes xxthe xxhospital
xxclient xxhas xxdeveloped xxswelling xxof xxthe xxeyelids xxand xxlips xxafter xxadministration
xxof xxa xxprescribed xxmedication. xxWhat xxdoes xxthe xxnursing xxattendant xxinterpret
xxthis xxfinding xxto xxspecifically xxindicate?
A) Mild xxallergic xxreaction
B) Anaphylactic xxshock
C) Angioedema
D) Drug xxidiosyncrasy
ACCURATE xxCHOICE:-C
Reasoning:->> xxAngioedema xxis xxa xxtype xxof xxallergic xxdrug xxreaction xxmanifested
xxby xxthe xxcollection xxof xxfluid xxin xxthe xxsubcutaneous xxtissues, xxmost xxcommonly
xxaffecting xxthe xxeyelids, xxlips, xxmouth, xxand xxthroat. xxAllergic xxreactions xxcan xxbe
xxmanifested xxby xxa xxwide xxrange xxof xxsigns xxand xxsymptoms xxsuch xxas xxitching,
xxrashes, xxand xxhives. xxAnaphylactic xxshock xxis xxa xxserious xxallergic xxreaction xxthat
xxrequires xximmediate xxmedical xxattention. xxDrug xxidiosyncrasy xxdescribes xxany
xxunusual xxor xxabnormal xxreaction xxto xxa xxdrug, xxone xxthat xxis xxdifferent xxfrom xxthe
xxone xxnormally xxexpected.
Question xx x x Format:
xxMultiple xxChoice xxChapter:
xx1
Learning xxObj: xx5 xxCognitive
xxLevel: xxApply
Hospital xxclient xxNeeds: xxPhysiological xxIntegrity: xxReduction xxof xxRisk
xxPotential xxIntegrated xxProcess: xxClinical xxProblem-solving xxProcess
xx(Nursing xxProcess) xxReference: xxp. xx12, xxAllergic xxDrug xxReactions
4. The xxnursing xxattendant xxis xxpreparing xxto xxteach xxa xxhospital xxclient xxabout xxa xxnew
xxdrug xxwhich xxis xxin xxthe xxfourth xxphase xxof xxdevelopment. xxWhich xxactivity xxwill
xxthe xxnursing xxattendant xxexplain xxbest xxillustrates xxthis xxphase?
A) Primary xxhealth xxcare xxproviders xxreport xxadverse xxeffects xxto xxFDA.
B) Healthy xxvolunteers xxare xxinvolved xxin xxthe xxtest.
C) In xxvitro xxtests xxare xxperformed xxusing xxhuman xxcells.
D) The xxdrug xxis xxgiven xxto xxhospital xxclients xxwith xxthe xxdisease.
ACCURATE xxCHOICE:-A